Cite
HARVARD Citation
Siskind, D. et al. (2018). CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ open. 8 (3), p. . [Online].